Metabolic reprogramming is a common hallmark shared by nearly all proliferating cancer cells, and thus has emerged as an exciting new direction in cancer research. Many signaling pathways have been implicated in mechanisms leading to the shift of metabolic programs in tumors, but more recently a small number of metabolic enzymes have also been identified in this process. Genes encoding the metabolic enzymes Isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2) were found to be mutated in up to 70% of low-grade and medium grade gliomas, and in 15-20% of adult acute leukemia samples. These findings were the first to link the IDH gene to tumorigenesis. IDH1 and IDH2 function to irreversibly catalyze the oxidative decarboxylation of isocitrate to α-ketoglutarate (α-KG). We are studying how mutations in IDH affect the metabolism and cellular processes of the cell. To this end, we have expressed IDH-R132H in Drosophila glial cells and hemoctyes to learn more about the impact of neomorphic activity of IDH in gliobastoma and chronic myeloid leukemia. We have verified that these cells now produce 2-HG, as is known in human tumors harboring IDH mutations. We have observed different cellular responses to IDH mutations in glia versus hemoctyes and have begun to investigate why this may be. Ultimately, the goal of our research is to elucidate the mechanism(s) that cause IDH to contribute to oncogenic activity in specific tissues, and use this knowledge to design tailored therapeutics. Citation Format: Julia Fabiano, Gabriela Chiaramida, Mira Magner, Meghan O'Connor, Joseph Stallone, Nicholas DiDuca, Kathryn Neville, Richard Tartarini, Marla Tipping. Using Drosophila to study the role of metabolic enzyme mutations in glioblastoma and leukemia [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 1827. doi:10.1158/1538-7445.AM2017-1827
Metabolic reprogramming has been detected in many diseases, including cancer. Recently, a small number of metabolic enzymes have been identified as driver mutations for various types of cancer. To better understand how these genes lead to cancer, and to identify molecular targets for treatment, we are investigating the isocitrate dehydrogenase (IDH) mutation implicated in human glioma and acute myeloid leukemia. We are currently using Drosophila melanogaster as a model to study both the metabolic changes that occur when IDH is mutated, and the potential impact on DNA damage repair pathways. To analyze metabolic changes in the brain of IDH mutant flies, we have optimized a protocol for measuring the metabolism of whole brains using the XFe96 metabolic analyzer. We have also detected the expression of D2-HG, a metabolite produced by mutant IDH in human cells, in our fly IDH model. Generation of D2-HG in human cells has been reported to correlate with insufficient DNA repair. To study this further we are testing for increased DNA damage and lack of DNA repair initiation. In particular, we are investigating a hypothesized connection between the Fanconi anemia DNA repair pathway and IDH mutations. Citation Format: Kathryn Neville, Elizabeth Arcand, Gabriela Chiaramida, Kaylie O'Connell, Marla Tipping. Breaking down cancer: IDH and its impact on metabolism and DNA damage and repair [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2017 Oct 26-30; Philadelphia, PA. Philadelphia (PA): AACR; Mol Cancer Ther 2018;17(1 Suppl):Abstract nr B018.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.